Herceptin

Latest articles

3d
The Economic Times
India is like a pregnant woman, still going through labour pains: Ravi Dharamshi, ValueQuestto last for five-seven years and I am being positively surprised by what is hap
The Economic Times / Posted 3 days ago
to last for five-seven years and I am being positively surprised by what is happening with Biocon's first similar which is Herceptin. Herceptin biosimilar that they have filed with Mylan. The timelines got it crunched. What we were expecting,... Read more
4d
Business Standard India
Roche's new breast cancer drug that could cut treatment time denied patentthe method, which has several advantages compared to intravenous injections, is
Business Standard India / Posted 4 days ago
the method, which has several advantages compared to intravenous injections, is useful in cancer drugs such as Trastuzumab (Herceptin) and Pertuzumab (Perjeta). The decision was taken in response to a national phase application Roche had filed in... Read more
5d
Financial News Network
Altrinsic Global Equities Trust - Monthly Report June 2017pricing across all segments. · In healthcare, the detailed results of Roche's
Financial News Network / Posted 5 days ago
pricing across all segments. · In healthcare, the detailed results of Roche's APHINITY clinical trial, which combined its Herceptin and Perjeta drugs to treat breast cancer versus Herceptin alone, disappointed the market. · Materials holding... Read more
6d
EuroNews
Poor test results for Roche cloud growth prospectsfirst of a threatened flood of biosimilar copies of Roche’s $22-billion-per-yea
EuroNews / Posted 6 days ago
first of a threatened flood of biosimilar copies of Roche’s $22-billion-per-year trio of cancer drugs, Rituxan, Avastin and Herceptin, have now been approved in Europe and the United States. Chief Executive Severin Schwan has long contended he can... Read more
8d
MedCity News
Puma's controversial cancer drug secures FDA approvalthe disease, neratinib is designed to lower the risk of a patient’s cancer recu
MedCity News / Posted 8 days ago
the disease, neratinib is designed to lower the risk of a patient’s cancer recurring after treatment with trastuzumab (Herceptin). As such, it’s prophylactic: A majority of women wouldn’t have experienced a recurrence either way. In a pivotal... Read more
3 related articles
11d
Business Standard India
Biocon cancer drug now only a step away from getting USFDA approvaltake place until 2019 as the drug is under patent in the country. Trastuzumab i
Business Standard India / Posted 11 days ago
take place until 2019 as the drug is under patent in the country. Trastuzumab is sold by drug maker Roche under brand name Herceptin and has a market size of $2.6 billion in the US. Biocon introduced Trastuzumab in India in 2014 and also sells it... Read more
3 related articles
11d
CNBC
JPM, WFC, C, WMT, BA, FCAU, T, GPS, SNAP & moreAdministration panel recommended approval of Mylan's Trastuzumab, a biosimilar
CNBC / Posted 11 days ago
Administration panel recommended approval of Mylan's Trastuzumab, a biosimilar version of the Genentech/Roche cancer drug Herceptin. PNC Financial – The bank earned $2.10 per share for the second quarter, eight cents a share above estimates.... Read more
11d
Business Standard India
US FDA approves Biocon's breast cancer biosimilar drugThe committee voted 16-0 in support of eligible indications of the reference pr
Business Standard India / Posted 11 days ago
The committee voted 16-0 in support of eligible indications of the reference product, Herceptin, which include HER2-positive breast cancer in the metastatic and adjuvant settings, Biocon and its partner Mylan said in a joint statement. Mylan... Read more
3 related articles
11d
The Economic Times
Big boost for Biocon as USFDA Onco committee approves company's first breast cancer biosimilar drugof a biologic innovator drug. Trastuzumab is an original drug of Swiss drug mak
The Economic Times / Posted 11 days ago
of a biologic innovator drug. Trastuzumab is an original drug of Swiss drug maker Roche which is sold under brand name of Herceptin, it is one of the most commonly used drug to treat HER2-positive breast cancer. Mylan and Biocon are exclusive... Read more
3 related articles
11d
Business Wire
Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Roche Holding AG To Contact The FirmAct of 1934 by virtue of the defendants’ failure to disclose during the Class P
Business Wire / Posted 11 days ago
Act of 1934 by virtue of the defendants’ failure to disclose during the Class Period that the combination of Perjeta and Herceptin for the treatment of breast cancer is only marginally more effective than Herceptin alone in preventing breast... Read more
15 related articles
12d
Market Watch
Mylan shares rise as FDA advisors recommend breast-cancer drug approvala Food and Drug Administration advisory committee recommended approval of its g
Market Watch / Posted 12 days ago
a Food and Drug Administration advisory committee recommended approval of its generic version of Roche's breast-cancer drug Herceptin. Mylan shares rose 1.3% to $39.55 after hours. The FDA's Oncologic Drugs Advisory Committee voted 16 to 0... Read more
3 related articles
17d
Salon.com
How do we know if a drug actually works?they are occasionally influenced by such subjectivity, however. In 2006 NICE ap
Salon.com / Posted 17 days ago
they are occasionally influenced by such subjectivity, however. In 2006 NICE approved the use of the breast cancer drug Herceptin for early-stage breast cancer following political pressure and a successful legal challenge by British woman... Read more
20d
Sydney Morning Herald
Canberra Now: News in 90 seconds for Thursday July 6, 2017pace, rare cancer sufferer Matt Owen says. His second chance at life has come
Sydney Morning Herald / Posted 20 days ago
pace, rare cancer sufferer Matt Owen says. His second chance at life has come at a cost - $230 per day to be precise. Herceptin is traditionally used to fight breast cancer and has been listed on the PBS since 2006, but for Matt it is not... Read more
20d
The Age
Canberra Now: News in 90 seconds for Thursday July 6, 2017pace, rare cancer sufferer Matt Owen says. His second chance at life has come
The Age / Posted 20 days ago
pace, rare cancer sufferer Matt Owen says. His second chance at life has come at a cost - $230 per day to be precise. Herceptin is traditionally used to fight breast cancer and has been listed on the PBS since 2006, but for Matt it is not... Read more
20d
Canberra Times
Pharmaceutical Benefits Scheme 'left behind' by changing cancer treatmentsin Canberra with dogs Stella and Buddy. Photo: Sitthixay Ditthavong A differen
Canberra Times / Posted 20 days ago
in Canberra with dogs Stella and Buddy. Photo: Sitthixay Ditthavong A different kind of cancer One of Matthew's drugs - Herceptin - is traditionally used to fight breast cancer and has been listed on the PBS since 2006. It "irritates" him that... Read more
2 related articles
20d
The Age
Pharmaceutical Benefits Scheme 'left behind' by changing cancer treatmentsin Canberra with dogs Stella and Buddy. Photo: Sitthixay Ditthavong A differen
The Age / Posted 20 days ago
in Canberra with dogs Stella and Buddy. Photo: Sitthixay Ditthavong A different kind of cancer One of Matthew's drugs - Herceptin - is traditionally used to fight breast cancer and has been listed on the PBS since 2006. It "irritates" him that... Read more
2 related articles
20d
Sydney Morning Herald
Pharmaceutical Benefits Scheme 'left behind' by changing cancer treatmentsin Canberra with dogs Stella and Buddy. Photo: Sitthixay Ditthavong A differen
Sydney Morning Herald / Posted 20 days ago
in Canberra with dogs Stella and Buddy. Photo: Sitthixay Ditthavong A different kind of cancer One of Matthew's drugs - Herceptin - is traditionally used to fight breast cancer and has been listed on the PBS since 2006. It "irritates" him that... Read more
2 related articles
20d
Business Wire
SmartZyme Adds Two Drug Development Veterans to Broaden and Strengthen Leadership TeamLeavitt. Christopher Shepard, Ph.D. Dr. Shepard began his career in 2002 at G
Business Wire / Posted 20 days ago
Leavitt. Christopher Shepard, Ph.D. Dr. Shepard began his career in 2002 at Genentech working on the team that developed Herceptin® (trastuzumab). Since that time, he has worked with research and development teams at Astellas, Celgene, and Merck... Read more
24d
FOX Business
Illumina, Inc. vs. Roche Holding Ltd.your sales can shrink overnight. Patents provide the primary moat for Roche. L
FOX Business / Posted 24 days ago
your sales can shrink overnight. Patents provide the primary moat for Roche. Last year, three cancer drugs -- Avastin, Herceptin, and Rituxan -- accounted for around 50% of all sales. It's great to have such important drugs on your roster, and... Read more
24d
FOX Business
Illumina, Inc. vs. Roche Holding Ltd.overnight. Continue Reading Below Patents provide the primary moat for Roche.
FOX Business / Posted 24 days ago
overnight. Continue Reading Below Patents provide the primary moat for Roche. Last year, three cancer drugs -- Avastin, Herceptin, and Rituxan -- accounted for around 50% of all sales. It's great to have such important drugs on your roster, and... Read more
25d
FOX Business
The 9 Best-Selling Prescription Drugs in 2016 (Each One Topped $6 Billion)favor of the new biosimilar, which means that nearly 35 million Americans no lo
FOX Business / Posted 25 days ago
favor of the new biosimilar, which means that nearly 35 million Americans no longer have access to the insulin drug. No. 8: Herceptin Roche's (NASDAQOTH: RHHBY) Herceptin generated sales totaling $6.75 billion in 2016. The drug is approved for... Read more
25d
FOX Business
The 9 Best-Selling Prescription Drugs in 2016 (Each One Topped $6 Billion)nearly 35 million Americans no longer have access to the insulin drug. Continu
FOX Business / Posted 25 days ago
nearly 35 million Americans no longer have access to the insulin drug. Continue Reading Below Roche's (NASDAQOTH: RHHBY) Herceptin generated sales totaling $6.75 billion in 2016. The drug is approved for treating breast, stomach, and esophageal... Read more
26d
iol.co.za
NHI white paper to be published on Fridayin fourth year) to be spent on childhood cancer. Motsoaledi said it cost the p
iol.co.za / Posted 26 days ago
in fourth year) to be spent on childhood cancer. Motsoaledi said it cost the private sector R24,000 to pay for one dose of herceptin, an effective treatment for some forms of breast cancer, with 17 doses being needed. Some medical aids don't pay... Read more
m
Business Wire
The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of Roche Holding AG Shareholders and a Lead Plaintiff Deadline of August 7, 2017made materially false and/or misleading statements and/or failed to disclose th
Business Wire / Posted 1 months ago
made materially false and/or misleading statements and/or failed to disclose that (1) the combination of Perjeta and Herceptin is only marginally more effective than Herceptin alone in preventing breast cancer; and (2) as a result,... Read more
3 related articles
m
Business Wire
Biopharmaceutical Contract Manufacturing Market (2nd Edition), 2017-2027overall pharmaceutical industry. Characterized by a number of blockbuster thera
Business Wire / Posted 1 months ago
overall pharmaceutical industry. Characterized by a number of blockbuster therapies (HUMIRA®, RITUXAN®, Lantus®, Avastin®, Herceptin® and REMICADE®) and a robust pipeline of product therapy candidates, the market is poised for significant growth in... Read more
m
iol.co.za
Why competition is key to cutting the cost of cancer drugs in South Africacan be used in combination with other drugs for some types of stomach cancer. R
iol.co.za / Posted 1 months ago
can be used in combination with other drugs for some types of stomach cancer. Roche’s branded versions of the medication is Herceptin. This is the only trastuzumab product currently available in South Africa. Pfizer provides the only crizotinib... Read more
2 related articles
m
AllAfrica.com
Why Competition Is Key to Cutting the Cost of Cancer Drugs in South Africacan be used in combination with other drugs for some types of stomach cancer. R
AllAfrica.com / Posted 1 months ago
can be used in combination with other drugs for some types of stomach cancer. Roche's branded versions of the medication is Herceptin. This is the only trastuzumab product currently available in South Africa. Pfizer provides the only crizotinib... Read more
2 related articles
m
Eye Witness News
[OPINION] Why competition is key to cutting the cost of cancer drugs in SAcan be used in combination with other drugs for some types of stomach cancer. R
Eye Witness News / Posted 1 months ago
can be used in combination with other drugs for some types of stomach cancer. Roche’s branded versions of the medication is Herceptin. This is the only trastuzumab product currently available in South Africa. Pfizer provides the only crizotinib... Read more
2 related articles
m
EveningTimes Online
Cancer survivor to join runners in night time 10k months after treatmentfinal session in spring, marked a total of 20 sessions of radiotherapy. Yvette
EveningTimes Online / Posted 1 months ago
final session in spring, marked a total of 20 sessions of radiotherapy. Yvette will be prescribed the breast cancer drug Herceptin for the next few years. Funding from Cancer Research UK allowed scientists to develop the drug and carry out... Read more
m
EveningTimes Online
Cancer survivor to take part in night time 10k months after treatmentfinal session in spring, marked a total of 20 sessions of radiotherapy. Yvette
EveningTimes Online / Posted 1 months ago
final session in spring, marked a total of 20 sessions of radiotherapy. Yvette will be prescribed the breast cancer drug Herceptin for the next few years. Funding from Cancer Research UK allowed scientists to develop the drug and carry out... Read more

In this news